GlisentideAlternative Names: Glipentide; Staticum
Latest Information Update: 03 Feb 1997
At a glance
- Originator Uriach
- Class Antihyperglycaemics; Benzamides; Cyclopentanes; Small molecules
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Type 2 diabetes mellitus
Most Recent Events
- 03 Feb 1997 Launched for Type-2 diabetes mellitus in Spain (PO)